β-2-microglobulin, neopterin and monocyte Fcγ receptors in opportunistic infections of HIV-positive patients

British Journal of Biomedical Science

Volumn 53, Issue 4, 1996, Pages 263-269

  Dunne, J ^a   Feighery, C ^a   Whelan, A ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

2 microglobulin; Fc R; HIV; Monocytes; Neopterin; Opportunistic infections

Indexed keywords

BETA 2 MICROGLOBULIN; CD14 ANTIGEN; CD4 ANTIGEN; CELL MARKER; FC RECEPTOR; NEOPTERIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MONOCYTE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPTERIN; HIV INFECTIONS; HUMANS; MONOCYTES; NEOPTERIN; RECEPTORS, IGG;

EID: 0030478868     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Centers for Disease Control, US Department of Health and Human Services, Atlanta, Georgia. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Ann Intern Med 1986; 105:234-7.
2. Moss AR, Bacchetti P, Osmond D et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow-up of the San Francisco General Hospital Cohort. BMJ 1988; 296:745-50.
3. Lang W, Perkins H, Anderson RE et al. Pattern of T-lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989; 2:63-9.
4. Lang W, Anderson RE, Perkins H et al. Clinical, immunologic and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco men's health study. JAMA 1987; 257:326-30.
5. Larder BA, Darby G, Richmann DD. HIV with reduced sensitivity to ziduvodine (AZT) isolated during prolonged therapy. Science 1989; 243:1731-4.
6. Anonymous. Zidovudine for symptomless HIV infection (Editorial). Lancet 1990; 335:821-2.
7. Cotton P. Controversy continues as experts ponder zidovudine's role in early HIV infection. JAMA 1990; 263:1605.
8. Anderson RE, Lang W, Shiboski S et al. Use of beta-2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Arch Intern Med 1987; 150: 73-7.
9. Fuchs D, Hausen A, Reibnegger G et al. Neopterin as a marker for activated cell-mediated immunity application in HIV infection. Immunol Today 1988; 5:150-5.
10. Bataille R, Magub M, Grenier J et al. Serum beta 2 microglobulin in multiple myeloma: relation to presenting features and clinical status. Eur J Cancer Clin Oncol 1982; 18:59-66.
11. Ziegler I. Synthesis and interferon-gamma controlled release of pteridines during activation of human peripheral blood mononuclear cells. Biochem Biophys Res Commun 1985; 132:404-11.
12. Guyre PM, Campbell AS, Kniffen WD, Fanger MW. Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type 1 IgG Fc receptors. J Clin Invest 1990; 86:1892-6.
13. Allen JB, Wong HL, Guyre PM et al. Association of circulating receptor FcRIII positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta. J Clin Invest 1991; 87:1773-9.
14. Capsoni F, Minonzio F, Ongari AM et al. Fc receptors expression and function in mononuclear phagocytes from AIDS patients: Modulation by IFN-gamma. Scand J Immunol 1994; 39:45-50.
15. Becton Dickinson UK Ltd, Between Townsend, GB-Cowley, Oxford OX4 3LY, England, UK.
16. Medarex, 1545 Route 22 East, PO Box 992, Annandale, New Jersey 08801-0992, USA.
17. Immunobiologic Laboratory, IBL, Flughafenstr. 52a. D-2000 Hamburg 63, Germany.
18. Pharmacia Diagnostics AB, Box 17, S-751 03, Uppsala 1, Sweden.
19. The Binding Site Ltd, Vincent Drive, Birmingham B15 2SQ, England, UK.
20. Cassuto JP, Krebs BP, Viot G et al. Beta-2 microglobulin, a tumour marker of lymphoproliferative disorders. Lancet 1978; ii:108-9.
21. Cooper RH, Forbes MA, Hambling MH. Serum β2-microglobulin and C-reactive protein concentrations in viral infections. J Clin Pathol 1984; 37:1140-3.
22. Fust G, Dierich MP, Hidvegi T. Role of humoral factors in progression of HIV disease. Immunol Today 1995; 16:167-9.
23. Homsy J, Meyer M, Tateno M et al. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 1989; 244:1357-60.
24. Connor RI, Dinces NB, Howell AL et al. Fc receptors for IgG on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including Fc gamma R. Proc Natl Acad Sci USA 1991; 88:9593-7.
25. Van Schie RC, Verstraten RG, Van de Winkle JG et al. Effect of recombinant IFN-gamma on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism. J Immunol 1992; 148:169-76.
26. Welch GR, Wong HL, Wahl SM. Selective induction of FcγRIII on human monocytes by transforming growth factor-β. J Immunol 1990; 144:3444-8.